Do antiepileptic drugs increase the risk of infectious diseases? A meta‐analysis of placebo‐controlled studies. (7th May 2017)

• Record Type: Journal Article
• Authors: Zaccara, Gaetano; Giovannelli, Fabio; Giorgi, Filippo Sean; Franco, Valentina; Gasparini, Sara; Tacconi, Francesco Mandò
• Is Part Of: British journal of clinical pharmacology. Volume 83:Number 9(2017)
• Page Start: 1873
• Page End: 1879
• Publication Date: 2017-05-07
• Subjects: adverse effects -- antiepileptic drugs -- infection -- medDRA -- meta‐analysis; Pharmacology -- Periodicals; Drugs -- Periodicals; 615.1
• DOI: 10.1111/bcp.13296
• Languages: English
• ISSNs: 0306-5251

Abstract

Abstract : Aims: Experimental studies show that some antiepileptic drugs (AEDs) may modify natural immune defences, thus influencing the risk of developing infectious diseases. The aim of this meta‐analysis was to explore whether AEDs as a class of drugs or singularly may increase risk of infectious diseases. Methods: A meta‐analysis of all randomized, double‐blind, placebo‐controlled trials (RCTs) investigating any AED in any condition was performed. All terms that could be coded in the System Organ Classes (SOCs) of infections and infestations using the Medical Dictionary for Regulatory Activities were recorded. Additional subanalyses were performed also pooling together AEDs sharing similar mechanisms of action. Results: Two hundreds and sixty‐nine double‐blind, placebo‐controlled studies were identified and, among them, 127 RCTs with 16 AEDs (brivaracetam, gabapentin, lacosamide, levetiracetam, lamotrigine, oxcarbazepine, perampanel, pregabalin, phenytoin, remacemide, retigabine, rufinamide, tiagabine, topiramate, valproate, zonisamide) reported at least one of 19 symptoms or diseases that could be included in the Medical Dictionary for Regulatory Activities SOC term infections and infestations . These terms were singularly recorded and then pooled together in the SOC term infection and infestation . Topiramate was significantly associated with an increased risk of infection (risk difference = 0.04; 95% confidence interval = 0.01/0.06), while oxcarbazepine was significantly associated with a lower risk (–0.005; –0.09/–0.01). Risk difference of all studies with all AEDs showed a slight, but significantly increased risk of infection (0.01; 0.00/0.002). Levetiracetam and brivaracetam RCTs, when pooled together, were associated with a significantly increased risk of infection (0.03; 0.01/0.05). Conclusions: Some AEDs are associated with a mild increased risk of infection.